3 Best Healthcare Stocks of 2017
The key to big gains last year? Start off small.
XOMA(XOMA)
Nasdaq Global Market
XOMA
$33.40
$0.89
2.7%
Price as of July 23, 2021, 4:00 p.m. ET
View Interactive XOMA Charts
A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.
Interactive Chart
Compare XOMA Stock to Peers
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
XOMA
XOMA
|
$33.40 | $366M | 79.3% | 195.1% |
|
CWBHF |
$3.23 | $566M | -9.1% | |
|
OGI |
$3.08 | $938M | 70.7% | 134.3% |
|
ANAB |
$25.75 | $706M | 23.6% | |
|
BVXP |
$3,980.00 | $21B | -2.5% | 423.2% |
News & Analysis: XOMA
The Fool has written over 100 articles on XOMA.
3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year
These three biotech stocks helped a lot of investors get rich this year. Are there more gains ahead?
Why XOMA Shares Are Crashing
XOMA's third quarter financial results failed to ignite investor enthusiasm today.
3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double
Wall Street has cast these three biotech stocks to the proverbial scrap heap over the past five years, but a big rebound may soon be in order.
Why XOMA Corp. Shares Rocketed Higher
XOMA shareholders press the launch button after the company begins the (approximate) countdown to a major news event.
How 1 Sentence Caused XOMA Corp. Shares to Explode Higher
XOMA Corp. released its first-quarter earnings results after the closing bell last night, but it was a single sentence from management, not its actually quarterly results, that has investors so excited today.
3 Things You Need to Know About XOMA Corp.
Thinking of investing in this high risk, high reward biotech stock? Here are three things you need to know first.
3 Little-Known Biotech Stocks I'm Keeping an Eye On
Neuralstem, Inc., Depomed Inc., and Xoma Corp. have news that could move them this year.
Is Xoma Corporation A Buy?
Xoma Corporation could release late stage trial data that could significantly move the stock.
Why XOMA Corp. Stock Plunged 37% in December
XOMA shareholders get blindsided by a combination of emotions and fundraising. Find out whether or not this dip is a reason to buy or a warning to keep your distance.
